Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Congratulations to the 2026 Fierce AI Innovation Awards Winners
Yescarta (axicabtagene ciloleucel)
Pharma
Gilead expanding access to Yescarta, Tecartus with Cencora deal
Cencora and Gilead have expanded their partnership, cutting a deal in which the distribution giant will support access to Yescarta and Tecartus.
Kevin Dunleavy
Jun 3, 2026 11:11am
FDA OKs BMS' Breyanzi as first CAR-T for marginal zone lymphoma
Dec 5, 2025 11:00am
Gilead reports 7% sales decline for CAR-Ts Yescarta, Tecartus
Aug 8, 2025 11:40am
FDA removes barrier to CAR-Ts; move likely to boost uptake
Jun 27, 2025 11:14am
BMS angles Breyanzi for another blood cancer
Feb 10, 2025 9:50am
Gilead's CAR-T sales stagnate as Trodelvy takes another write-off
Nov 7, 2024 11:16am
